Enliven Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$34.51

+3.36 (+10.79%)

As of Mar 25, 1:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target -8.2% upside

Low Target $20.91

Average Target $31.67

High Target $36.06

Current Price $34.51

Current
$34.51

Target
$31.67

$20.91 $31.67 avg $36.06

Scenario Analysis

Bear Case

$20.91

-39.4%

Low target

Base Case

$31.67

-8.2%

Avg target

Bull Case

$36.06

+4.5%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$30.63

12.7% from high

52-Week Low

$13.30

+159.5% from low

Target vs 52W High

$31.67

+3.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%